Treasurer of the State of North Carolina’s BridgeBio Pharma BBIO Stock Holding History

Treasurer of the State of North Carolina’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.36M	Buy	+72,010	New	+$5.04M	0.01%	663

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Treasurer of the State of North Carolina's BBIO Position: Q2 2026 in Review

Treasurer of the State of North Carolina opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 72,010 shares worth $5.36M. The stake represents 0.01% of the portfolio and ranks #663 among its holdings.

474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Treasurer of the State of North Carolina held 72,010 shares of BridgeBio Pharma worth $5.36M as of Q2 2026.
BridgeBio Pharma was a new Treasurer of the State of North Carolina position in Q2 2026.
BridgeBio Pharma made up 0.01% of Treasurer of the State of North Carolina's portfolio in Q2 2026, its #663 holding.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2026, filed 14 Aug 2026.